Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. Th…

Medical - Devices

US, Hercules [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Bio-Rad Laboratories, Inc.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	2.7200	3.365	2,132	2,191	77	66	329	266	169	126	798	755
2015	3.0800	3.510	2,175	2,019	88	85	312	232	149	128	808	600
2016	3.7400	3.034	2,019	2,066	113	4	309	245	166	29	761	1,205
2017	0.8800	2.963	2,068	2,159	28	138	273	260	115	99	816	820
2018	4.1200	5.369	2,160	2,282	114	491	289	814	128	-55	808	741
2019	12.1000	7.210	2,290	2,328	360	1,379	366	1,890	191	193	833	693
2020	58.9300	9.810	2,311	2,442	1,758	2,889	389	522	229	317	824	608
2021	127.8600	15.309	2,545	2,885	3,814	2,268	573	617	410	361	800	679
2022	142.6100	14.395	2,922	2,816	4,254	-2,009	650	-904	489	376	879	627
2023	-121.7900	11.484	2,802	2,675	-3,627	-637	664	-995	482	413	827	689
2024	-21.8200	10.274	2,671	2,580	-637	300	576	551	383	376	820	812
2025	-	11.650	-	2,673	-	340	-	571	-	389	-	841
2026	-	13.084	-	2,801	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	15.100	-	2,919	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	17.350	-	3,066	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

Underweight

Prev. Grade

Underweight

Nov. 6, 2024

Equal-Weight

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-19.351% $64.42 · MISS

Nov. 6, 2024

Price Then

$374.28

Price Target

$397.33

Price Now

$332.91